These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9154276)

  • 21. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.
    Giles H; Bolofo ML; Lydford SJ; Martin GR
    Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
    Sharif NA; Kelly CR; Crider JY
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
    Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
    Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
    Yousufzai SY; Ye Z; Abdel-Latif AA
    Exp Eye Res; 1996 Sep; 63(3):305-10. PubMed ID: 8943703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
    Sharif NA; McLaughlin MA; Kelly CR; Xu S; Crider JY; Williams GW; Parker JL
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 15-Fluoro prostaglandin FP agonists: a new class of topical ocular hypotensives.
    Klimko P; Hellberg M; McLaughlin M; Sharif N; Severns B; Williams G; Haggard K; Liao J
    Bioorg Med Chem; 2004 Jul; 12(13):3451-69. PubMed ID: 15186831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter.
    Ansari HR; Davis AM; Kaddour-Djebbar I; Abdel-Latif AA
    J Ocul Pharmacol Ther; 2003 Jun; 19(3):217-31. PubMed ID: 12828840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandins: a new approach to glaucoma management with a new, intriguing side effect.
    Bito LZ
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S1-14. PubMed ID: 9154271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug].
    Nomura S; Hashimoto M
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):280-6. PubMed ID: 10872179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).
    Woodward DF; Krauss AH; Chen J; Liang Y; Li C; Protzman CE; Bogardus A; Chen R; Kedzie KM; Krauss HA; Gil DW; Kharlamb A; Wheeler LA; Babusis D; Welty D; Tang-Liu DD; Cherukury M; Andrews SW; Burk RM; Garst ME
    J Pharmacol Exp Ther; 2003 May; 305(2):772-85. PubMed ID: 12606640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
    Goh Y; Nakajima M; Azuma I; Hayaishi O
    Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PGF2 alpha/pilocarpine interactions on IOP and accommodation in monkeys.
    Millar JC; Kaufman PL
    Exp Eye Res; 1995 Dec; 61(6):677-83. PubMed ID: 8846839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural requirements for prostaglandin analog interaction with the ovine corpus luteum prostaglandin F2 alpha receptor. Implications for development of a photoaffinity probe.
    Balapure AK; Rexroad CE; Kawada K; Watt DS; Fitz TA
    Biochem Pharmacol; 1989 Jul; 38(14):2375-81. PubMed ID: 2751699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of nitric oxide in PGF2 alpha-induced ocular hyperemia.
    Astin M; Stjernschantz J; Selén G
    Exp Eye Res; 1994 Oct; 59(4):401-7. PubMed ID: 7532135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ocular pharmacokinetics of eicosanoids and their derivatives. 1. Comparison of ocular eicosanoid penetration and distribution following the topical application of PGF2 alpha, PGF2 alpha-1-methyl ester, and PGF2 alpha-1-isopropyl ester.
    Bito LZ; Baroody RA
    Exp Eye Res; 1987 Feb; 44(2):217-26. PubMed ID: 3472899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure.
    Woodward DF; Williams LS; Chen J
    Ophthalmic Res; 1989; 21(6):428-35. PubMed ID: 2626239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prostaglandin F2alpha, latanoprost and carbachol on phosphoinositide turnover, MAP kinases, myosin light chain phosphorylation and contraction and functional existence and expression of FP receptors in bovine iris sphincter.
    Ansari HR; Kaddour-Djebbar I; Abdel-Latif AA
    Exp Eye Res; 2004 Feb; 78(2):285-96. PubMed ID: 14729360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintained reduction of intraocular pressure by prostaglandin F2 alpha-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients.
    Camras CB; Siebold EC; Lustgarten JS; Serle JB; Frisch SC; Podos SM; Bito LZ
    Ophthalmology; 1989 Sep; 96(9):1329-36; discussion 1336-7. PubMed ID: 2780003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
    Ota T; Aihara M; Narumiya S; Araie M
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.